These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8234901)

  • 41. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
    Goso C; Astolfi M; Parlani M; Manzini S
    Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors.
    Maggi CA; Giuliani S; Patacchini R; Santicioli P; Theodorsson E; Barbanti G; Turini D; Giachetti A
    Gastroenterology; 1992 Jan; 102(1):88-96. PubMed ID: 1370160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insertion of an aspartic acid moiety into cyclic pseudopeptides: synthesis and biological characterization of potent antagonists for the human Tachykinin NK-2 receptor.
    Fedi V; Altamura M; Balacco G; Canfarini F; Criscuoli M; Giannotti D; Giolitti A; Giuliani S; Guidi A; Harmat NJ; Nannicini R; Pasqui F; Patacchini R; Perrotta E; Tramontana M; Triolo A; Maggi CA
    J Med Chem; 2004 Dec; 47(27):6935-47. PubMed ID: 15615542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth muscles.
    Maggi CA; Giuliani S; Patacchini R; Quartara L; Rovero P; Renzetti AR; Mizrahi J; Giachetti A
    Neuropeptides; 1992 Nov; 23(3):181-6. PubMed ID: 1335134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
    Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
    Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
    Maggi CA; Giuliani S; Ballati L; Lecci A; Manzini S; Patacchini R; Renzetti AR; Rovero P; Quartara L; Giachetti A
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1172-8. PubMed ID: 1710662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach.
    Zagorodnyuk V; Maggi CA
    Neuroscience; 1997 Sep; 80(2):625-34. PubMed ID: 9284363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor.
    Nguyen-Le XK; Nguyen QT; Gobeil F; Pheng LH; Emonds-Alt X; Brelière JC; Regoli D
    Pharmacology; 1996 May; 52(5):283-91. PubMed ID: 8807672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tachykinin NK1 but not NK2 receptors mediate non-cholinergic excitatory junction potentials in the circular muscle of guinea-pig colon.
    Zagorodnyuk V; Santicioli P; Maggi CA
    Br J Pharmacol; 1993 Oct; 110(2):795-803. PubMed ID: 8242253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.
    Kudlacz EM; Shatzer SA; Knippenberg RW; Logan DE; Poirot M; van Giersbergen PL; Burkholder TP
    J Pharmacol Exp Ther; 1996 May; 277(2):840-51. PubMed ID: 8627566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of tachykinin NK1 and NK2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs.
    Lecci A; Giuliani S; Tramontana M; Giorgio RD; Maggi CA
    Br J Pharmacol; 1998 May; 124(1):27-34. PubMed ID: 9630339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.
    Maggi CA; Patacchini R
    Br J Pharmacol; 1992 Aug; 106(4):888-92. PubMed ID: 1327390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different Ca2+ influx pathways mediate tachykinin receptor-induced contraction in circular muscle of guinea-pig colon.
    Zagorodnyuk V; Santicioli P; Maggi CA
    Eur J Pharmacol; 1994 Apr; 255(1-3):9-15. PubMed ID: 7517885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
    Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
    Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insertion of 2-carboxysuccinate and tricarballylic acid fragments into cyclic-pseudopeptides: new antagonists for the human tachykinin NK-2 receptor.
    Harmat NJ; Giannotti D; Nannicini R; Perrotta E; Criscuoli M; Patacchini R; Renzetti AR; Giuliani S; Altamura M; Maggi CA
    Bioorg Med Chem Lett; 2002 Feb; 12(4):693-6. PubMed ID: 11844703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tachykinin receptor assays.
    Meini S; Maggi CA
    Curr Protoc Pharmacol; 2010 Mar; Chapter 4():Unit 4.10. PubMed ID: 22294370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.